We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Silence Therapeutics has launched legal action alleging that late stage drugs from rivals Alnylam and The Medicines Company infringe its intellectual property.